Effect of Danshen for improving clinical outcomes in patients with bladder cancer: a retrospective, population-based study
Yi-Hsin Chen, Chih-Tsung Chen, Han-Ping Wu · 2023
Read Effect of Danshen for improving clinical outcomes in patients with bladder cancer: a retrospective, population-based study by Yi-Hsin Chen, Chih-Tsung Chen, Han-Ping Wu (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10749307.txt.
Description
Yi-Hsin Chen, Chih-Tsung Chen, and Han-Ping Wu published this 2023 study on a traditional herb and heart risk in bladder cancer patients. Danshen, a staple of Chinese medicine, is often taken alongside cancer care in Taiwan. The team asked whether patients who used it fared differently on major heart events and survival.
From national insurance records spanning 2003 to 2013, they formed three groups: 525 patients on Danshen, 6,419 with no traditional medicine, and 4,356 on other traditional formulas. Major heart events struck five percent of the Danshen group, against about eight and ten percent in the other groups. After adjustment, Danshen users also showed the lowest death risk. The authors urge trials to test whether the herb truly protects.
Catalog record
| CREATOR | Yi-Hsin Chen, Chih-Tsung Chen, Han-Ping Wu |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 27 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |